Publications of Yvonne Genzel
All genres
Meeting Abstract (20)
2017
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
2014
Meeting Abstract
31 Supplement, p. S180. (2014)
The impact of MDCK cell source on the production of influenza and canine adenovirus. In New Biotechnology: Abstracts of the 16th European Congress on Biotechnology, 2011
Meeting Abstract
5 (S8 ), P129. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. In BMC Proceedings,
Meeting Abstract
5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, 2010
Meeting Abstract
82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), p. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. (2010)
Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 2009
Meeting Abstract
81 (8), p. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, September 08, 2009 - September 10, 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)
Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 2006
Meeting Abstract
Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, p. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, October 01, 2006 - October 05, 2006. (2006)
Talk (126)
2024
Talk
Shaking to very high cell densities - perfusion for virus production. Kuhner Large Scale Meeting, Girona (Spain) (2024)
Talk
Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yield. 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI), Rio de Janeiro (Brazil) (2024)
Talk
Engineered defective interfering particles of influenza A virus for antiviral treatment. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
Talk
Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)
Talk
Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)
2023
Talk
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17th Vaccine Congress, Glasgow (Scotland) (2023)
Talk
ESACT Course on Cell Culture-based Viral Vaccines (8th Edition): Exercise on vaccine design. ESACT Course 2023, Llafranc (Spain) (2023)
Talk
ESACT Course on Cell Culture-based Viral Vaccines (8th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2023, Llafranc (Spain) (2023)
Talk
ESACT Course on Cell Culture-based Viral Vaccines (8th Edition):Upstream Process Intensification. ESACT Course 2023, Llafranc (Spain) (2023)
Talk
ESACT Course on Cell Culture-based Viral Vaccines (8th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2023, Llafranc (Spain) (2023)
Talk
Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16th PEACe Conference, Sitges (Spain) (2023)
Talk
Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)
Talk
Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)